Skip to main content
. 2020 Feb 12;177(8):1917–1930. doi: 10.1111/bph.14961

Table 1.

Functional affinity (pK B) and cooperativity (Logαβ) parameters for CaS receptor modulators determined in Ca2+ i mobilisation assays, as described

Ronacaleret ATF936 Pfizer compound 1 BMS compound 1
pK B Logαβ (αβ) n pK B Logαβ (αβ) n pK B Logαβ (αβ) n pK B Logαβ (αβ) n
WT 6.35 ± 0.09 −1.56 ± 0.16 (0.03) 6 7.59 ± 0.10 −2.30 ± 0.15 (0.005) 6 7.82 ± 0.14 −2.03 ± 0.13 (0.009) 5 6.97 ± 0.07 −1.47 ± 0.05 (0.03) 12
F6682.56A NA NA 4 7.76 ± 0.09 −2.37 ± 0.16 (0.004) 5 7.35 ± 0.14 −1.34 ± 0.13* (0.05) 5 7.26 ± 0.12 −2.08 ± 0.13* (0.008) 5
G670ECL1A 6.90 ± 0.08* −1.29 ± 0.05 (0.05) 5 8.21 ± 0.05* −2.61 ± 0.08 (0.002) 5 8.27 ± 0.05 −2.17 ± 0.05 (0.007) 5 6.87 ± 0.09 −1.58 ± 0.08 (0.03) 5
R6803.32A NA NA 3 7.56 ± 0.10 −1.90 ± 0.13 (0.01) 5 6.67 ± 0.19* −0.97 ± 0.10* (0.11) 5 6.73 ± 0.10 −1.12 ± 0.07 (0.08) 5
F6843.36A NA NA 3 NA NA 3 NA NA 4 6.70 ± 0.10 −2.02 ± 0.32* (0.009) 5
F6883.40A NA NA 3 NA NA 3 NA NA 4 6.70 ± 0.10 −1.92 ± 0.27 (0.01) 5
E767ECL2A 6.43 ± 0.12 −1.17 ± 0.11 (0.07) 5 8.24 ± 0.09* −3.35 ± 0.27* (0.0004) 5 8.33 ± 0.09* −2.55 ± 0.10* (0.003) 5 7.88 ± 0.11* −2.32 ± 0.12* (0.005) 5
W8186.50A 7.94 ± 0.07* −1.96 ± 0.06 (0.01) 5 5.78 ± 0.26* −0.52 ± 0.12* (0.30) 5 7.39 ± 0.07 −2.29 ± 0.13 (0.005) 5 7.32 ± 0.12 −1.12 ± 0.07 (0.08) 5
F8216.53A NA NA 4 NA NA 4 NA NA 4 NA NA 4
Y8256.56A NA NA 3 7.18 ± 0.10 −1.90 ± 0.14 (0.01) 5 7.91 ± 0.07 ~ − 100 5 6.82 ± 0.09 −1.93 ± 0.15 (0.01) 5
E8377.32I NA NA 3 7.97 ± 0.09 −2.18 ± 0.12 (0.007) 5 6.44 ± 0.12* −1.17 ± 0.09* (0.07) 5 6.06 ± 0.11* −1.31 ± 0.20 (0.05) 5
I8417.36A NA NA 4 6.64 ± 0.11* −1.24 ± 0.11* (0.06) 5 6.62 ± 0.15* −0.88 ± 0.07* (0.13) 5 6.50 ± 0.13* −1.37 ± 0.11 (0.04) 6

Note. Data are mean ± SEM from the indicated number of independent experiments (n). NA denotes not determined due to no or weak modulator activity.

*

P < .05, significantly different from WT; one‐way ANOVA with Dunnett's multiple comparisons post test.